Ericsson, world’s biggest telecom network equipment maker few months ago filed a patent infringement suit against Micromax, one of India’s largest domestic mobile handset manufacturers for allegedly infringing 8 of its telecom patents for a range of wireless technologies, including 3G, AMR and Edge The suit, filed at the Delhi High Court, involves a [...]
US Patent Application Number US 20130048020 A1 Titled “Oral care implement” sounds to be related to some dental implants or likewise but after going through the patent application one can easily find out that the patent application filed by Colgate-Palmolive Company revealed technology that would allow chemicals to be embedded into the heads of [...]
After the news that Novartis failed to secure an Indian patent for Glivec, the patenting woes of Western pharma in India seem to continue as Merck are denied interim relief in a patent case against Glenmark. The decision came within days of Merck’s subsidiary, MSD India, dragging the domestic company to court over the [...]
Post Novartis Glivec case ruling competition between MNC pharmaceuticals & Indian generic companies gets fierce as US based Merck Sharp & Dohme (MSD), the third largest pharma company by revenues , has filed a patent infringement suit with Delhi High court against domestic generic company Glenmark Pharmaceuticals. MSD move comes a week after Glenmark [...]
India’s Supreme Court has set an important precedent in refusing to grant a patent to Novartis for an updated version of its cancer drug Glivec. The verdict will allow generic drug makers within the country to continue selling cheap versions of the drug, which is used to treat chronic myeloid leukemia and other cancers. [...]
Every Morning in a Indian House starts with a cup of tea & a news on smartphone companies like HTC, Motorola, Apple fighting the patent wars, but it seems that the Smartphone patent war has been finally arrived in India too. Ericsson, world’s biggest telecom network equipment maker has recently filed a patent infringement [...]
